Cargando…
PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells
Colorectal cancer (CRC) is a prevalent worldwide disease in which the antioxidant enzyme peroxiredoxin 2 (PRDX2) plays an important role. To investigate the molecular mechanism of PRDX2 in CRC, we performed bioinformatics analysis of The Cancer Genome Atlas (TCGA) datasets and Gene Expression Omnibu...
Autores principales: | Zheng, Xiangru, Wei, Jinlai, Li, Wenjun, Li, Xiaoli, Wang, Wuyi, Guo, Jinbao, Fu, Zhongxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485722/ https://www.ncbi.nlm.nih.gov/pubmed/32692719 http://dx.doi.org/10.18632/aging.103690 |
Ejemplares similares
-
PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53
por: Wang, Wuyi, et al.
Publicado: (2021) -
Sestrin2 reduces cancer stemness via Wnt/β-catenin signaling in colorectal cancer
por: Wei, Jinlai, et al.
Publicado: (2022) -
Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer
por: Lv, Zhenbing, et al.
Publicado: (2017) -
Repurposing Oxiconazole against Colorectal Cancer via PRDX2-mediated Autophagy Arrest
por: Shi, Jinyu, et al.
Publicado: (2022) -
Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway
por: Xu, Jun, et al.
Publicado: (2017)